ArticleEBioMedicine2019

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1

Mathias Schneeweiss-Gleixner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.